[1]
Mohanad K. Mohamed et al. 2022. Panretinal versus targeted retinal photocoagulation with and without intra-vitreal ranibizumab in proliferative diabetic retinopathy. Journal of Population Therapeutics and Clinical Pharmacology. 29, 04 (Aug. 2022), 513–522. DOI:https://doi.org/10.53555/jptcp.v29i04.1670.